1. Home
  2. BDMD vs ACTU Comparison

BDMD vs ACTU Comparison

Compare BDMD & ACTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDMD
  • ACTU
  • Stock Information
  • Founded
  • BDMD 2012
  • ACTU 2015
  • Country
  • BDMD China
  • ACTU United States
  • Employees
  • BDMD N/A
  • ACTU N/A
  • Industry
  • BDMD
  • ACTU
  • Sector
  • BDMD
  • ACTU
  • Exchange
  • BDMD NYSE
  • ACTU NYSE
  • Market Cap
  • BDMD 203.3M
  • ACTU 135.0M
  • IPO Year
  • BDMD N/A
  • ACTU 2024
  • Fundamental
  • Price
  • BDMD $5.59
  • ACTU $8.00
  • Analyst Decision
  • BDMD
  • ACTU Strong Buy
  • Analyst Count
  • BDMD 0
  • ACTU 1
  • Target Price
  • BDMD N/A
  • ACTU $20.00
  • AVG Volume (30 Days)
  • BDMD 33.9K
  • ACTU 42.0K
  • Earning Date
  • BDMD 01-01-0001
  • ACTU 05-21-2025
  • Dividend Yield
  • BDMD N/A
  • ACTU N/A
  • EPS Growth
  • BDMD 578.78
  • ACTU N/A
  • EPS
  • BDMD 0.43
  • ACTU N/A
  • Revenue
  • BDMD $33,048,249.00
  • ACTU N/A
  • Revenue This Year
  • BDMD N/A
  • ACTU N/A
  • Revenue Next Year
  • BDMD N/A
  • ACTU N/A
  • P/E Ratio
  • BDMD $13.10
  • ACTU N/A
  • Revenue Growth
  • BDMD N/A
  • ACTU N/A
  • 52 Week Low
  • BDMD $1.05
  • ACTU $5.51
  • 52 Week High
  • BDMD $13.52
  • ACTU $11.73
  • Technical
  • Relative Strength Index (RSI)
  • BDMD N/A
  • ACTU N/A
  • Support Level
  • BDMD N/A
  • ACTU N/A
  • Resistance Level
  • BDMD N/A
  • ACTU N/A
  • Average True Range (ATR)
  • BDMD 0.00
  • ACTU 0.00
  • MACD
  • BDMD 0.00
  • ACTU 0.00
  • Stochastic Oscillator
  • BDMD 0.00
  • ACTU 0.00

About BDMD BAIRD MEDICAL INVESTMENT HLDGS LTD

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Share on Social Networks: